The pres, does mention it
"Sozinibercept is being developed for use in combination with any of the existing anti-VEGF-A agents, biosimilars, or novel therapies in development for wAMD...The $15bn global market comprised of Eylea, Vabysmo, Lucentis revenue plus an estimate for biosimilars, Avastin off-label, and Beovu of ~$1bn"
The pres, does mention it"Sozinibercept is being developed for...
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.010(2.74%) |
Mkt cap ! $403.8M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.8¢ | 36.0¢ | $351.8K | 949.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 231714 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 15101 | 5 |
View Market Depth
| Last trade - 14.35pm 11/07/2024 (20 minute delay) ? |
| OPT (ASX) Chart |